Articles
| Open Access |
DOI: Immune-mediated differentiation of autism subtypes: evidence from pediatric Neurocytokine profiling in central Asia
Farangisbonu Alisher qizi Doniyorova , PhD., Associate professor, Department of the nervous diseases, Tashkent state dental institute, Tashkent. UzbekistanAbstract
This study investigates immunological distinctions between clinical subtypes of autism spectrum disorder (ASD), focusing on pediatric populations diagnosed with Kanner’s and Asperger’s syndromes. Utilizing quantitative analysis of serum cytokines—IL-6, TNF-α, IL-10, and IL-1β—we evaluated immune deviations in relation to behavioral severity and neurocognitive function. The data revealed subtype-specific inflammatory patterns, with heightened IL-6 and TNF-α in Kanner’s syndrome and selective IL-1β elevation in Asperger’s syndrome. A deficiency in IL-10 was common across both groups, suggesting impaired anti-inflammatory modulation. These results underscore the role of immune biomarkers in refining ASD subtypes and tailoring early interventions.
Keywords
Autism spectrum disorder, Kanner syndrome, Asperger syndrome
References
Meltzer A, Van de Water J. Neuropsychopharmacology. 2017;42(1):284–298.
Bjørklund G, et al. Immunol Res. 2020;68(4):358–370.
Siniscalco D, et al. J Neuroimmunol. 2015;287:80–85.
Goines P, Ashwood P. Neurotoxicol Teratol. 2013;36:67–81.
Li X, et al. Neurosci Bull. 2019;35(6):1059–1070.
Navarro L, et al. Cytokine Growth Factor Rev. 2022;64:1–10.
Careaga M, et al. Biol Psychiatry. 2017;81(5):434–441.
Rose DR, et al. J Neuroinflammation. 2018;15(1):1–13.
Ghali S, et al. Brain Sci. 2021;11(10):1295.
Piras IS, et al. Mol Autism. 2020;11(1):1–27.
Ashwood P, et al. Brain Behav Immun. 2011;25(5):840–847.
Garbett KA, et al. Transl Psychiatry. 2012;2(5):e65.
Garay PA, et al. Front Neurosci. 2013;7:123.
Article Statistics
Copyright License
Copyright (c) 2025 Farangisbonu Alisher qizi Doniyorova
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.